Canaloplasty microcatheter receives clearance

Article

iScience Interventional has been granted 510k clearance from the FDA for its canaloplasty microcatheter for the catheterization and viscodilation of the Schlemm's canal in adult patients with primary open-angle glaucoma (POAG).

iScience Interventional has been granted 510k clearance from the FDA for its canaloplasty microcatheter for the catheterization and viscodilation of the Schlemm's canal in adult patients with primary open-angle glaucoma (POAG).

Canaloplasty, a minimally-invasive surgical technique, uses a 250 micron microcatheter to access the drainage channels and enlarge them allowing the canal to function normally again, thus lowering intraocular pressure (IOP).

Michael Nash, President of iScience Interventional, commented, "Microcatheters represent an exciting new frontier for ophthalmology. We believe that interventional procedures will significantly alter the paradigm for a wide range of eyes diseases and disorders in the future."

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.